Literature DB >> 19846871

The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.

Naoko Satoh-Takayama1, Laure Dumoutier, Sarah Lesjean-Pottier, Vera S G Ribeiro, Ofer Mandelboim, Jean-Christophe Renauld, Christian A J Vosshenrich, James P Di Santo.   

Abstract

Natural cytotoxicity receptors (including NKp30, NKp44, and NKp46 in humans and NKp46 in mice) are type I transmembrane proteins that signal NK cell activation via ITAM-containing adapter proteins in response to stress- and pathogen-induced ligands. Although murine NKp46 expression (encoded by Ncr1) was thought to be predominantly restricted to NK cells, the identification of distinct intestinal NKp46(+) cell subsets that express the transcription factor Rorc and produce IL-22 suggests a broader function for NKp46 that could involve intestinal homeostasis and immune defense. Using mice carrying a GFP-modified Ncr1 allele, we found normal numbers of gut CD3(-)GFP(+) cells with a similar cell surface phenotype and subset distribution in the absence of Ncr1. Splenic and intestinal CD3(-)NKp46(+) cell subsets showed distinct patterns of cytokine secretion (IFN-gamma, IL-22) following activation via NK1.1, NKp46, IL-12 plus IL-18, or IL-23. However, IL-22 production was sharply restricted to intestinal CD3(-)GFP(+) cells with the CD127(+)NK1.1(-) phenotype and could be induced in an Ncr1-independent fashion. Because NKp46 ligands can trigger immune activation in the context of infectious pathogens, we assessed the response of wild-type and Ncr-1-deficient Rag2(-/-) mice to the enteric pathogen Citrobacter rodentium. No differences in the survival or clinical score were observed in C. rodentium-infected Rag2(-/-) mice lacking Ncr1, indicating that NKp46 plays a redundant role in the differentiation of intestinal IL-22(+) cells that mediate innate defense against this pathogen. Our results provide further evidence for functional heterogeneity in intestinal NKp46(+) cells that contrast with splenic NK cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19846871     DOI: 10.4049/jimmunol.0901935

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Innate immune natural killer cells and their role in HIV and SIV infection.

Authors:  Pavel Bostik; Yoshiaki Takahashi; Ann E Mayne; Aftab A Ansari
Journal:  HIV Ther       Date:  2010-07-01

2.  Attenuation of intestinal inflammation in interleukin-10-deficient mice infected with Citrobacter rodentium.

Authors:  Sara M Dann; Christine Le; Barun K Choudhury; Houpu Liu; Omar Saldarriaga; Elaine M Hanson; Yingzi Cong; Lars Eckmann
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

Review 3.  Cytokine crowdsourcing: multicellular production of TH17-associated cytokines.

Authors:  Kathleen O Busman-Sahay; Travis Walrath; Samuel Huber; William O'Connor
Journal:  J Leukoc Biol       Date:  2014-12-29       Impact factor: 4.962

Review 4.  Tissue-specific effector functions of innate lymphoid cells.

Authors:  Niklas K Björkström; Eliisa Kekäläinen; Jenny Mjösberg
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

Review 5.  Interactions between the intestinal microbiota and innate lymphoid cells.

Authors:  Vincent L Chen; Dennis L Kasper
Journal:  Gut Microbes       Date:  2013-12-16

Review 6.  Activation and Suppression of Group 3 Innate Lymphoid Cells in the Gut.

Authors:  Wenqing Zhou; Gregory F Sonnenberg
Journal:  Trends Immunol       Date:  2020-07-06       Impact factor: 16.687

Review 7.  Interleukin-22: a likely target for treatment of autoimmune diseases.

Authors:  Xuyan Yang; Song Guo Zheng
Journal:  Autoimmun Rev       Date:  2014-01-10       Impact factor: 9.754

8.  Decreased serum level of IL-21 in new-onset systemic lupus erythematosus patients.

Authors:  Hai-Feng Pan; Guo-Cui Wu; Yin-Guang Fan; Rui-Xue Leng; Hui Peng; Mo Zhou; Bao-Zhu Li; Yan Zhu; Jin-Hui Tao; Xiang-Pei Li; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2013-03-29       Impact factor: 2.631

9.  Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages.

Authors:  Parinaz Aliahmad; Brian de la Torre; Jonathan Kaye
Journal:  Nat Immunol       Date:  2010-09-05       Impact factor: 25.606

10.  Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues.

Authors:  Jochem H Bernink; Charlotte P Peters; Marius Munneke; Anje A te Velde; Sybren L Meijer; Kees Weijer; Hulda S Hreggvidsdottir; Sigrid E Heinsbroek; Nicolas Legrand; Christianne J Buskens; Willem A Bemelman; Jenny M Mjösberg; Hergen Spits
Journal:  Nat Immunol       Date:  2013-01-20       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.